Patents by Inventor Marie-Laure RIVES

Marie-Laure RIVES has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CLASS OF MU-OPIOID RECEPTOR AGONISTS
    Publication number: 20220106279
    Abstract: The present invention provides a compound having the structure: or a pharmaceutically acceptable salt or ester thereof.
    Type: Application
    Filed: July 6, 2021
    Publication date: April 7, 2022
    Applicant: THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
    Inventors: Andrew C. Kruegel, Adam Henke, Madalee G. Wulf, Marie-Laure Rives, Jonathan A. Javitch, Dalibor Sames
  • NEW CLASS OF MU-OPIOID RECEPTOR AGONISTS
    Publication number: 20190084949
    Abstract: The present invention provides a compound having the structure: or a pharmaceutically acceptable salt or ester thereof.
    Type: Application
    Filed: November 16, 2018
    Publication date: March 21, 2019
    Applicant: THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
    Inventors: Andrew C. Kruegel, Adam Henke, Madalee M. Wulf, Marie-Laure Rives, Jonathan A. Javitch, Dalibor Sames
  • Class of mu-opioid receptor agonists
    Patent number: 10183919
    Abstract: The present invention provides a compound having the structure: or a pharmaceutically acceptable salt or ester thereof.
    Type: Grant
    Filed: March 12, 2015
    Date of Patent: January 22, 2019
    Assignee: THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
    Inventors: Andrew C. Kruegel, Adam Henke, Madalee M. Gassaway, Marie-Laure Rives, Jonathan A. Javitch, Dalibor Sames
  • Kappa opioid receptor selective compounds, compositions, and uses thereof
    Patent number: 9868730
    Abstract: The present invention provides, inter alia, compounds of formula (I): (structurally represented). Also provided are pharmaceutical compositions containing such compounds and methods for treating or ameliorating the effects of a medical condition in a subject using such compounds or pharmaceutical compositions.
    Type: Grant
    Filed: February 14, 2014
    Date of Patent: January 16, 2018
    Assignees: The Trustees of Columbia University in the City of New York, Icahn School of Medicine at Mount Sinai
    Inventors: Jonathan Javitch, Marie-Laure Rives, Marta Filizola, Thomas E. Prisinzano
  • A NEW CLASS OF MU-OPIOID RECEPTOR AGONISTS
    Publication number: 20170217913
    Abstract: The present invention provides a compound having the structure: or a pharmaceutically acceptable salt or ester thereof.
    Type: Application
    Filed: March 12, 2015
    Publication date: August 3, 2017
    Applicant: THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
    Inventors: Andrew C. Kruegel, Adam Henke, Madalee M. Gassaway, Marie-Laure Rives, Jonathan A. Javitch, Dalibor Sames
  • KAPPA OPIOID RECEPTOR SELECTIVE COMPOUNDS, COMPOSITIONS, AND USES THEREOF
    Publication number: 20160002216
    Abstract: The present invention provides, inter alia, compounds of formula (I): (structurally represented). Also provided are pharmaceutical compositions containing such compounds and methods for treating or ameliorating the effects of a medical condition in a subject using such compounds or pharmaceutical compositions.
    Type: Application
    Filed: February 14, 2014
    Publication date: January 7, 2016
    Inventors: Jonathan JAVITCH, Marie-Laure RIVES, Marta FILIZOLA, Thomas E, PRISINZANO